0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

XOLAIR Marketed Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

XOLAIR Marketed Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
Benralizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Benralizumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
EUR$3,250USDGBP
From
EUR$3,950USDGBP
From
EUR$7,500USDGBP
From
EUR$7,500USDGBP
From
EUR$7,500USDGBP
From
EUR$3,950USDGBP
Nasal Polyposis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Nasal Polyposis - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 80 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$4,750USDGBP
From
EUR$7,500USDGBP
Bronchopulmonary Dysplasia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Epidemiology Forecast - 2032

  • Drug Pipelines
  • March 2022
  • 62 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$7,500USDGBP
Pleural Effusion - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pleural Effusion - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Sinusitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sinusitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$3,950USDGBP
From
EUR$3,950USDGBP
ARDS - Epidemiology Forecast to 2032 - Product Thumbnail Image

ARDS - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Acute Pharyngitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Acute Pharyngitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Bronchial Spasm - Epidemiology Forecast - 2032 - Product Thumbnail Image

Bronchial Spasm - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more